Calamos Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-35,133
| Closed | -$3.2M | – | 903 |
|
|
2023
Q2 | $3.2M | Sell |
35,133
-512
| -1% | -$46.6K | 0.02% | 595 |
|
|
2023
Q1 | $2.35M | Buy |
+35,645
| New | +$2.35M | 0.01% | 704 |
|
|
2020
Q2 | – | Sell |
-12,882
| Closed | -$345K | – | 691 |
|
|
2020
Q1 | $345K | Buy |
+12,882
| New | +$345K | ﹤0.01% | 658 |
|